Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 17/20 | 0.43 |
| ▸ | CACNA1G | O43497 | 1/20 | 0.41 |
| ▸ | CACNA1H | O95180 | 1/20 | 0.41 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14619991 | 0.88 | CYP3A4 (0.43) | CYP3A4CACNA1GCACNA1HCACNA1I | |
| SCHEMBL13745302 | 0.88 | CYP3A4 (0.53) | CYP3A4 | |
| SCHEMBL14620233 | 0.88 | CYP3A4 (0.40) | CYP3A4CACNA1GCACNA1HCACNA1I | |
| SCHEMBL13745304 | 0.87 | CYP3A4 (0.47) | CYP3A4 | |
| SCHEMBL14629401 | 0.87 | CYP3A4 (0.40) | CYP3A4 | |
| SCHEMBL14629370 | 0.87 | CYP3A4 (0.41) | CYP3A4 | |
| SCHEMBL13745200 | 0.87 | CLPP (0.46) | CYP3A4 | |
| SCHEMBL13744946 | 0.86 | CYP3A4 (0.47) | CYP3A4 | |
| SCHEMBL748026 | 0.85 | MEN1 (0.40) | CYP3A4 | |
| SCHEMBL13745195 | 0.85 | CLPP (0.55) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | CHOONGWAE PHARMA CORPORATION (KR) | 2009-08-27 | — | — | US | disclosed |
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | CHOONGWAE PHARMA CORPORATION (KR) | 2009-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090215783-A1 | COMPOSITION FOR INDUCTION OR INHIBITION OF STEM CELL DIFFERENTIATION | MYLK2, TNNC1, MYH2 | CYP3A4 4483/4885CACNA1G 2927/4885CACNA1H 2992/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.